The Henry Ford Stroke and Neurovascular Center is a leader in pioneering new treatments for stroke and is recognized worldwide for our clinical research. Henry Ford ranks in the top 20 percent in the United States of all National Institutes of Health (NIH)-funded institutions for stroke research, with multiple program, project and individual grants.
This means patients at Henry Ford have access to treatment options not always available at other hospitals and rarely offered in a true collaborative, team setting. Doctors specializing in various aspects of stroke management are currently collaborating on a variety of clinical trials.
Neuroregeneration research at Henry Ford
Henry Ford is at the forefront of healing the nervous system. Henry Ford neuroscientists have pioneered a new and exciting field of neuroregeneration research, which aims to find new drug and cell therapies that work to remodel the brain and spinal cord after injury from disease such as stroke. Learn more about our Neuroregeneration Research Center.
Clinical trials for stroke at Henry Ford
As leaders in the field of cerebrovascular treatment and neurocritical care, Henry Ford’s cerebrovascular team participates in NIH clinical trials and other studies. Examples include:
- Interventional Management of Stroke (IMS) trials
- Carotid Revascularization Endarterectomy versus Stenting Trial (CREST)
- Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMM PRIS)
- The CLEAR-III study on intraventricular thrombolysis with tPA in patients with intraventricular hemorrhage from an intraparenchymal bleed
- The ATACH -II study on blood pressure control in patients with acute intracerebral hemorrhage
- The CLASH study regarding tight blood pressure control in patients with subarachnoid hemorrhage with a novel calcium channel blocker
- High-dose statin use and MRI after spontaneous intracerebral hemorrhage
- Coagulation reversal in intracranial bleeds